These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15202848)

  • 41. Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.
    Hamaguchi T; Shimada Y; Mizusawa J; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Takiguchi N; Yatsuoka T; Takii Y; Ojima H; Masuko H; Kubo Y; Mishima H; Yamaguchi T; Bando H; Sato T; Kato T; Nakamura K; Fukuda H; Moriya Y
    Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):47-56. PubMed ID: 29079411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Onycholysis with the appearance of a "sunset" secondary to capecitabine.
    Maino KL; Norwood C; Stashower ME
    Cutis; 2003 Sep; 72(3):234-6. PubMed ID: 14533836
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy of the combined use of taurine for hyperbilirubinemia caused by UFT therapy after surgery for colonic cancer].
    Miyata K; Ikawa O; Izumi H; Shimomura K; Matsumura H; Kakihara N; Katoh Y; Ohgaki M; Iizuka R; Fujii K; Shimotsuma M; Tkenaka A
    Gan To Kagaku Ryoho; 2006 May; 33(5):671-3. PubMed ID: 16685170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Adjuvant chemotherapy with S-1 for advanced head and neck carcinoma].
    Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():172-8. PubMed ID: 16897997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Study on the intensity of MMC and UFT in postoperative adjuvant chemotherapy for gastric cancer--study report of JFMTC Study No. 10].
    Danno M; Shiroto H; Kunii Y; Ishibiki K; Yamamura Y; Sakamoto Y; Tamura Y; Kunitomo K; Kumashiro R;
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):195-203. PubMed ID: 11242646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case of advanced colon cancer treated with preoperative chemotherapy (IRIS) leading to clinical complete response].
    Sato R; Iwaya A; Takii Y; Ohta T
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1367-70. PubMed ID: 19692781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of suspected vasospastic angina related to S-1 administration.
    Shitara K; Kameda K; Hoshi Y; Munakata M; Muto O; Sakata Y
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1705-8. PubMed ID: 17940396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial.
    Ito S; Ohashi Y; Sasako M
    BMC Cancer; 2018 Apr; 18(1):449. PubMed ID: 29678146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma.
    Shinkawa H; Uenishi T; Takemura S; Sakata C; Urata Y; Nozawa A; Hamano G; Kinoshita M; Kubo S
    Hepatogastroenterology; 2015; 62(137):169-74. PubMed ID: 25911890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feasibility and toxicity of adjuvant chemotherapy using S-1 granules for local advanced squamous cell carcinoma of the head and neck.
    Suzuki S; Honda K; Sato T; Yamazaki K; Ishikawa K
    J Chemother; 2015 Oct; 27(5):297-300. PubMed ID: 25971448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Alternate-day oral therapy with S-1 for adjuvant chemotherapy of gastric cancer].
    Takebayashi K; Kawai Y; Tagi T; Matsumura M; Shimizu K; Yamamoto H; Mekata E; Tani T; Sato M
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):385-7. PubMed ID: 22421764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and pharmacokinetics of S-1 in a recurrent colon cancer patient with chronic myeloid leukemia treated with dasatinib: a case report.
    Sueda T; Kudo T; Sakai D; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Ezoe S; Matsumoto K; Doki Y; Mori M; Satoh T
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1321-4. PubMed ID: 25374410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Biochemical modulation by leucovorin of the antineoplastic effect of fluorofur in disseminated colorectal cancer].
    Manziuk LV; Perevodchikova NI; Gorbunova VA; Luk'ianchenko AB; Abramova NA
    Vopr Onkol; 1996; 42(3):33-6. PubMed ID: 8801738
    [No Abstract]   [Full Text] [Related]  

  • 54. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
    Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T
    Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates.
    Tsuchiya T; Nagayasu T; Yamasaki N; Matsumoto K; Miyazaki T; Tagawa T; Nakamura A; Minami H; Taniguchi H; Akamine S; Hisano H; Taniguchi Y
    Clin Lung Cancer; 2012 Nov; 13(6):464-9. PubMed ID: 22424872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer.
    Lamberti C; Sauerbruch T; Glasmacher A
    Cancer Treat Rev; 2005 Dec; 31(8):648-52. PubMed ID: 16289340
    [No Abstract]   [Full Text] [Related]  

  • 57. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
    Wang HF; Lv JQ
    Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy.
    Tabuse H; Kashiwagi H; Hamauchi S; Tsushima T; Todaka A; Yokota T; Machida N; Yamazaki K; Fukutomi A; Onozawa Y; Mori K; Boku N; Ichinose M; Yasui H
    Gastric Cancer; 2016 Jul; 19(3):894-901. PubMed ID: 26362271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma.
    Rubiales AS; del Valle ML
    Cancer; 1999 Apr; 85(8):1866-7. PubMed ID: 10223583
    [No Abstract]   [Full Text] [Related]  

  • 60. UFT/leucovorin vs 5-FU/leucovorin in colon cancer.
    Smith RE; Lembersky BC; Wieand HS; Colangelo L; Mamounas EP
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):24-7. PubMed ID: 11098486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.